Wird geladen...
Management of acneiform rash associated with anti-EGFR monoclonal antibody treatment
Introduction. Dermatologic adverse events (DAEs) occur in 50-90% of cases during anti-EGFR monoclonal antibody treatment. Positive correlation between the severity of acneiform rash (AR) and the effectiveness of anti-EGFR management is established. Low effectiveness of traditional treatment for AR i...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Russo |
| Veröffentlicht: |
Remedium Group LLC
2020-12-01
|
| Schriftenreihe: | Медицинский совет |
| Schlagworte: | |
| Online Zugang: | https://www.med-sovet.pro/jour/article/view/5951 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|